IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Ask Genius
Genius — OpenServe
News
Home
Popular
Sections
Elections
Library
Play
Ask Genius
Ask Genius
Genius — OpenServe
Trending
Alpha DaRT Pembrolizumab Combo Shows 100% Response
Health
— Jul 21, 2026
Alpha Tau Medical reported positive data from a single-center study of Alpha DaRT combined with pembrolizumab in elderly patients with locally advanced or metastatic head and neck cancer, achieving a 100% systemic objective response rate and an 18.2-month median overall survival with no serious Alpha DaRT-related adverse events. The results, presented at the AHNS conference in Boston, exceeded historical pembrolizumab benchmarks and support continued trials and the company’s strategic push in immuno-oncology, with analyst notes highlighting a Buy rating for DRTS.
+4
Share
Biotech Firms Plan Global Investor Conferences
Health
— Aug 31, 2026
Multiple biotech companies announced management participation in upcoming investor conferences, including Surrozen, Ascentage Pharma, Alpha Tau, Nurix Therapeutics, and Processa Pharmaceuticals. Surrozen will present at two healthcare conferences; Ascentage Pharma will participate in four; Alpha Tau’s CFO will attend multiple investor meetings; Nurix will host fireside chats; and Processa will present at Wells Fargo’s and H.C. Wainwright’s conferences following its Vidya Therapeutics acquisition.
+2
Share
Alpha Architect ETFs Report Sharp August Short-Interest Decline
Finance
— Aug 25, 2026
Several ETFs saw substantial cuts to short interest in August, signaling shifts in investor positioning: Alpha Architect Tail Risk ETF (CAOS) saw short interest plunge about 90.9%, Alpha Architect Aggregate Bond ETF (BOXA) fell roughly 96.2%, Abacus FCF International Leaders ETF (ABLG) dropped about 96.7%, Cultivar ETF (CVAR) declined around 98.7%, and FT Vest U.S. Equity Moderate Buffer ETF – March (GMAR) decreased by roughly 99.1%. Across these funds, short-selling activity and days-to-cover shrank dramatically as traders recalibrated risk exposures and liquidity moves persisted.
+730
Share
DAVID BLACKMON: Tesla Could Be On The Brink Of ‘Blackberry Moment’
x/tesla
— Mar 23, 2025
Analysts at the investor advisory site Seeking Alpha published a piece on Tuesday in which they claim that Tesla could be facing what they call a “Blackberry moment” caused by a combination of political and market…
Share
IJR
Californians Trade In Over 1,000 E-Bikes As Injuries Abound Nationwide
Elizabeth Bandelin · 3 min · 13h
Researchers Report First Known Death Linked to Tick-Triggered Meat Allergy
x/alpha-gal-syndrome
— Nov 14, 2025
Researchers say they have identified what appears to be the first documented death caused by alpha-gal syndrome — a severe meat allergy triggered by certain tick bites — after a 47-year-old New Jersey man died last year…
Share
Most Influential Women in World History
Yourlist
— Ranking
From ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.
Share
ArcelorMittal releases Q2 2026 consensus
x/goldman-sachs-group-inc
— Jul 24, 2026
ArcelorMittal's second-quarter 2026 sell-side consensus points to approximately $2.04 billion in EBITDA, $802 million in net income, and $1.06 per share, derived from 13 of about 15 covering brokers via Visible Alpha. The company stresses these figures are external analyst estimates, not its guidance or its own validation of the forecasts.
Share
Fifth Third Bancorp Buys 109,308 Bath & Body Works Shares, Expands Stake
Business
— Jul 21, 2026
Fifth Third Bancorp expanded its Bath & Body Works stake by purchasing 109,308 shares, while Alpha Family Trust added 8,855 shares of Fifth Third Bancorp; additionally, Fifth Third’s COO converted stock appreciation rights into 31,639 shares and executed related tax-withholding dispositions.
+111
Share
